Clinical Trial: A Prospective, Single-Arm, Exploratory Clinical Study of QL1706 Combined with Chemotherapy with or without Bevacizumab for Recurrent/Metastatic Cervical Cancer Progressed after Immunotherapy (China)

Posted On: 2026-10-21

China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Single-Arm, Exploratory Clinical Study of QL1706 Combined with Chemotherapy with or without Bevacizumab for Recurrent/Metastatic Cervical Cancer Progressed after Immunotherapy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134691

Registration Time: 2026/10/19

Type: Interventional study

Primary Sponsor: Sun Yat-sen University Cancer Center (Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Sun Yat-sen University Cancer Institute)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348256

Published by HT Digital Content Services with ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Prospective, Single-Arm, Exploratory Clinical Study of QL1706 Combined with Chemotherapy with or without Bevacizumab for Recurrent/Metastatic Cervical Cancer Progressed after Immunotherapy (China)